GL Ventures

Activity from announced rounds

Activity in this selectionkaratage-7ecba3c3
Rounds participated in
6
Confirmed lead rounds
1
4 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$623M
6 disclosed · full round size, not this investor’s share

By stage

Undisclosed4
Series B2

By primary sector

Biotech3
AI2
Hardware1

By country

United States3
China2
Singapore1

Rounds

6 in this selection
Anew Labs

An AI drug-discovery company that combines molecular models, experimental biology and a drug pipeline to identify and develop new medicines.

$290MFunding
Lead
Clipto

Clipto builds AI tools for searching and working with video and audio libraries.

$15MFunding
Participant
LTZ Therapeutics

Develops immunotherapies to harness myeloid biology for cancer treatment

$38MUndisclosed
Role not disclosed
Syneron Bio

Develops intelligent platform-driven macrocyclic peptide drug discovery

$150MSeries B
Role not disclosed
Dify

Helps teams build deploy and operate production-grade AI applications and agentic workflows

$30MPre-Series A
Role not disclosed
EPG

Provides modular and prefabricated data center infrastructure

$100MSeries B
Role not disclosed